139 related articles for article (PubMed ID: 37307066)
1. Blinking Parameters Do Not Normalize After Botulinum Toxin Therapy in Blepharospasm and Hemifacial Spasm Patients.
Gameiro GR; Osaki MH; Yabumoto C; Osaki T; Garcia DM; Belfort R; Cruz AAV; Osaki TH
J Neuroophthalmol; 2023 Dec; 43(4):563-568. PubMed ID: 37307066
[TBL] [Abstract][Full Text] [Related]
2. An objective tool to measure the effect of botulinum toxin in blepharospasm and hemifacial spasm.
Osaki MH; Osaki TH; Garcia DM; Osaki T; Gameiro G; Belfort R; Cruz AAV
Eur J Neurol; 2020 Aug; 27(8):1487-1492. PubMed ID: 32294304
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin and blink rate in patients with blepharospasm and increased blinking.
Ferrazzano G; Conte A; Fabbrini G; Bologna M; Macerollo A; Defazio G; Hallett M; Berardelli A
J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):336-40. PubMed ID: 24963123
[TBL] [Abstract][Full Text] [Related]
4. A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques.
Lolekha P; Choolam A; Kulkantrakorn K
Neurol Sci; 2017 Nov; 38(11):2031-2036. PubMed ID: 28884242
[TBL] [Abstract][Full Text] [Related]
5. Objective demonstration of eyelid spasm relief with smartphone and custom software in hemifacial spasm patients.
Gameiro GR; Yabumoto C; Osaki MH; Monteiro LG; Schor P; Osaki TH
Int Ophthalmol; 2024 Mar; 44(1):144. PubMed ID: 38498055
[TBL] [Abstract][Full Text] [Related]
6. [Essential blepharospasm and hemifacial spasm: characteristic of the patient, botulinum toxin A treatment and literature review].
Schellini SA; Matai O; Igami TZ; Padovani CR; Padovani CP
Arq Bras Oftalmol; 2006; 69(1):23-6. PubMed ID: 16491229
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
Ababneh OH; Cetinkaya A; Kulwin DR
Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
[TBL] [Abstract][Full Text] [Related]
8. Long-term adherence and response to botulinum toxin in different indications.
Lee JI; Jansen A; Samadzadeh S; Kahlen U; Moll M; Ringelstein M; Soncin G; Bigalke H; Aktas O; Moldovan AS; Waskoenig J; Jander S; Gliem M; Schnitzler A; Hartung HP; Hefter H; Albrecht P
Ann Clin Transl Neurol; 2021 Jan; 8(1):15-28. PubMed ID: 33259153
[TBL] [Abstract][Full Text] [Related]
9. Influence of involuntary eyelid spasms on corneal topographic and eyelid morphometric changes in patients with hemifacial spasm.
Osaki T; Osaki MH; Osaki TH; Hirai FE; Nallasamy N; Campos M
Br J Ophthalmol; 2016 Jul; 100(7):963-970. PubMed ID: 26541432
[TBL] [Abstract][Full Text] [Related]
10. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study.
Kongsengdao S; Kritalukkul S
J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S48-54. PubMed ID: 22619887
[TBL] [Abstract][Full Text] [Related]
11. Corneal and Tear Film Changes After Botulinum Toxin-A in Blepharospasm or Hemifacial Spasm.
Gunes A; Demirci S; Koyuncuoglu HR; Tok L; Tok O
Cornea; 2015 Aug; 34(8):906-10. PubMed ID: 26075455
[TBL] [Abstract][Full Text] [Related]
12. Blepharospasm with elevated anti-acetylcholine receptor antibody titer.
Tang M; Li W; Liu P; He F; Ji F; Meng F
Arq Neuropsiquiatr; 2018 Aug; 76(8):522-526. PubMed ID: 30231125
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes.
Cillino S; Raimondi G; Guépratte N; Damiani S; Cillino M; Di Pace F; Casuccio A
Eye (Lond); 2010 Apr; 24(4):600-7. PubMed ID: 19648904
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of carbamazepine combined with botulinum toxin a in the treatment of blepharospasm and hemifacial spasm.
Li XH; Lin SC; Hu YF; Liu LY; Liu JB; Hong YC
Eye Sci; 2012 Dec; 27(4):178-81. PubMed ID: 23225838
[TBL] [Abstract][Full Text] [Related]
15. Botulinum Toxin for the Treatment of Hemifacial Spasm: An Update on Clinical Studies.
Tambasco N; Filidei M; Nigro P; Parnetti L; Simoni S
Toxins (Basel); 2021 Dec; 13(12):. PubMed ID: 34941718
[TBL] [Abstract][Full Text] [Related]
16. The long-term response to botulinum toxin injections in patients with blepharospasm undergoing upper eyelid surgery.
Trinchillo A; Cuomo N; Habetswallner F; Esposito M
Parkinsonism Relat Disord; 2024 Feb; 119():105958. PubMed ID: 38118281
[TBL] [Abstract][Full Text] [Related]
17. Facial asymmetry in patients with hemifacial spasm before and after botulinum toxin A treatment.
Xiao L; Pan Y; Zhang X; Hu Y; Cai L; Nie Z; Pan L; Li B; He Y; Jin L
Neurol Sci; 2016 Nov; 37(11):1807-1813. PubMed ID: 27431279
[TBL] [Abstract][Full Text] [Related]
18. The role of the injection botulinum toxin A in cases of blepharospasm syndrome, hemifacial spasm and Meige's syndrome.
Bastola P; Chaudhary M; Agrawal JP; Shah DN
Kathmandu Univ Med J (KUMJ); 2010; 8(31):305-10. PubMed ID: 22610735
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation.
Thussu A; Barman CR; Prabhakar S
Neurol India; 1999 Sep; 47(3):206-9. PubMed ID: 10514580
[TBL] [Abstract][Full Text] [Related]
20. Tear meniscus, corneal topographic and aberrometric changes after botulinum toxin-a injection in patients with blepharospasm and hemifacial spasm.
Bayraktar Bilen N; Bilen Ş; Topçu Yılmaz P; Evren Kemer Ö
Int Ophthalmol; 2022 Aug; 42(8):2625-2632. PubMed ID: 35355169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]